• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用冷冻的天然粪便进行复发性感染的粪便微生物群移植:一种提高供体粪便准备效率的简单方法。

Use of frozen native feces for fecal microbiota transplantation in recurrent infection: a simple way to improve the efficiency of donor feces preparation.

机构信息

Department of Pharmacy, Sorbonne Université, AP-HP, Saint-Antoine Hospital, Paris, France.

Assistance Publique-Hopitaux de Paris (AP-HP) FMT Center, Paris, France.

出版信息

Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0073424. doi: 10.1128/aac.00734-24. Epub 2024 Aug 21.

DOI:10.1128/aac.00734-24
PMID:39166867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459919/
Abstract

Preparing fecal microbiota transplants immediately after donation is resource-intensive, and a proportion are destroyed following abnormal screening results. We retrospectively compared two processes, frozen fecal preparation (FFP) and fresh native frozen preparation (FNFP), for clinical efficacy in the treatment of recurrent infection (rCDI). FFP and FNFP were similarly effective with clinical success rates of 76.7% and 86.7% ( = 0.32), respectively. FNFP is an efficient procedure that saves resources while maintaining clinical efficacy in rCDI.

摘要

制备粪便微生物群移植(FMT)供体样本后立即进行移植的方式资源消耗大,而且一部分供体样本会因为异常的筛查结果而被销毁。我们回顾性比较了两种方法,即冷冻粪便准备(FFP)和新鲜冷冻原生粪便准备(FNFP),以评估它们在治疗复发性感染(rCDI)中的临床疗效。FFP 和 FNFP 的临床成功率分别为 76.7%和 86.7%(=0.32),二者疗效相当。FNFP 是一种有效的方法,在保持 rCDI 临床疗效的同时节约了资源。

相似文献

1
Use of frozen native feces for fecal microbiota transplantation in recurrent infection: a simple way to improve the efficiency of donor feces preparation.使用冷冻的天然粪便进行复发性感染的粪便微生物群移植:一种提高供体粪便准备效率的简单方法。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0073424. doi: 10.1128/aac.00734-24. Epub 2024 Aug 21.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Host origin of microbiota drives functional recovery and clearance in mice.微生物群的宿主来源驱动小鼠的功能恢复和清除。
mBio. 2025 Jun 2:e0110825. doi: 10.1128/mbio.01108-25.
4
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS.用于预防PUNCH CD3-OLS中炎症性肠病患者复发性艰难梭菌感染的活粪微生物群制剂-jslm(REBYOTA®)的安全性和有效性
Inflamm Bowel Dis. 2025 Jan 25. doi: 10.1093/ibd/izae291.
5
Fecal Microbiome Transplantation for Recurrent CDI: Treatment Efficacy and Safety with Oral Capsules.粪便微生物群移植治疗复发性艰难梭菌感染:口服胶囊的治疗效果与安全性
J Gastrointestin Liver Dis. 2025 Jun 28;34(2):199-204. doi: 10.15403/jgld-5990.
6
Lyophilised fecal microbiota transfer in capsules for recurrent Clostridioides difficile infection.用于复发性艰难梭菌感染的冻干粪菌移植胶囊
Int J Antimicrob Agents. 2025 Oct;66(4):107561. doi: 10.1016/j.ijantimicag.2025.107561. Epub 2025 Jul 1.
7
Faecal microbiota transplantation for recurrent Clostridiodes difficile infection & its global regulatory landscape.粪菌移植治疗复发性艰难梭菌感染及其全球监管格局。
Indian J Med Res. 2025 Feb;161(2):113-119. doi: 10.25259/IJMR_818_2024.
8
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.粪菌移植治疗艰难梭菌感染:一项系统评价
J Clin Gastroenterol. 2014 Sep;48(8):693-702. doi: 10.1097/MCG.0000000000000046.
9
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.系统评价与荟萃分析:粪便微生物群移植治疗复发性和难治性艰难梭菌感染的疗效
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493. doi: 10.1111/apt.14201. Epub 2017 Jul 14.
10
Fecal microbiota live - jslm (Rebyota™/RBL) for management of recurrent infection.用于治疗复发性感染的粪便微生物群活菌制剂-jslm(Rebyota™/RBL)
Future Microbiol. 2024;19(14):1243-1251. doi: 10.1080/17460913.2024.2364583. Epub 2024 Jul 11.

引用本文的文献

1
Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation.艰难梭菌感染中的粪便微生物群移植(FMT):胃肠道微生物组调节的范式转变
Cureus. 2025 May 29;17(5):e85054. doi: 10.7759/cureus.85054. eCollection 2025 May.

本文引用的文献

1
Effect of cryopreservation medium conditions on growth and isolation of gut anaerobes from human faecal samples.冷冻保护剂条件对人粪便样本中肠道厌氧菌的生长和分离的影响。
Microbiome. 2022 May 30;10(1):80. doi: 10.1186/s40168-022-01267-2.
2
Faecal microbiota transplantation for recurrent infection: An updated systematic review and meta-analysis.粪便微生物群移植治疗复发性感染:一项更新的系统评价和荟萃分析。
EClinicalMedicine. 2020 Nov 23;29-30:100642. doi: 10.1016/j.eclinm.2020.100642. eCollection 2020 Dec.
3
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.粪便微生物群移植治疗艰难梭菌感染:机制与药理学。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):67-80. doi: 10.1038/s41575-020-0350-4. Epub 2020 Aug 25.
4
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.在一项随机、双盲、安慰剂对照研究中评估粪便微生物群移植治疗肠易激综合征患者的疗效。
Gut. 2020 May;69(5):859-867. doi: 10.1136/gutjnl-2019-319630. Epub 2019 Dec 18.
5
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.国际共识会议关于粪便银行在临床实践中进行粪便微生物群移植。
Gut. 2019 Dec;68(12):2111-2121. doi: 10.1136/gutjnl-2019-319548. Epub 2019 Sep 28.
6
A Guide for Ex Vivo Handling and Storage of Stool Samples Intended for Fecal Microbiota Transplantation.粪便微生物群移植用粪便样本的离体处理和储存指南
Sci Rep. 2019 Jun 20;9(1):8897. doi: 10.1038/s41598-019-45173-4.
7
Efficacy of different faecal microbiota transplantation protocols for infection: A systematic review and meta-analysis.不同粪便微生物群移植方案治疗感染的疗效:一项系统评价和荟萃分析。
United European Gastroenterol J. 2018 Oct;6(8):1232-1244. doi: 10.1177/2050640618780762. Epub 2018 Jun 3.
8
European consensus conference on faecal microbiota transplantation in clinical practice.临床实践中粪便微生物群移植欧洲共识会议
Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13.
9
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.粪便过滤移植治疗艰难梭菌感染的疗效。
Gastroenterology. 2017 Mar;152(4):799-811.e7. doi: 10.1053/j.gastro.2016.11.010. Epub 2016 Nov 17.
10
Understanding the mechanisms of faecal microbiota transplantation.了解粪便微生物群移植的机制。
Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):508-16. doi: 10.1038/nrgastro.2016.98. Epub 2016 Jun 22.